Nano Dimension proposes to acquire Infinite Epigenics in all-stock business combination

Nano Dimension has proposed acquiring 100% of Infinite Epigenetics through a reverse merger, with Infinite shareholders receiving Nano stock based on an agreed exchange ratio derived from company valuations. The transaction values Infinite at $890 million and represents a significant M&A activity for the Israeli-incorporated tech company.